Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
PRAX Praxis Precision Medicines
- 76.520
- +3.680+5.05%
Close Dec 20 16:00 ET
- 76.150
- -0.370-0.48%
Post 17:59 ET
1.43BMarket Cap-8.34P/E (TTM)
79.400High71.250Low530.84KVolume71.250Open72.840Pre Close40.50MTurnover3.49%Turnover RatioLossP/E (Static)18.64MShares86.93052wk High3.73P/B1.16BFloat Cap19.61052wk Low--Dividend TTM15.20MShs Float914.258Historical High--Div YieldTTM11.19%Amplitude11.850Historical Low76.286Avg Price1Lot Size
Praxis Precision Medicines News
Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating
Praxis Precision Medicines (PRAX) Gets a Buy From Truist Financial
H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $120
Praxis Precision Med Price Target Maintained With a $120.00/Share by HC Wainwright & Co.
Praxis Precision Medicine Analyst Ratings
Jefferies Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $305
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270
Piper Sandler Gives a Buy Rating to Praxis Precision Medicines (PRAX)
A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $114 to $120
Praxis Precision Medicines: Strong Buy Rating Amid Potential Upside and Robust Pipeline Despite Operational Challenges
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $120 Price Target
A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $114 to $170
Praxis Precision Medicine Analyst Ratings
Wedbush Raises Praxis Precision Medicines Price Target to $57 From $51, Maintains Neutral Rating
Optimistic Buy Rating for Praxis Precision Medicines Amid Strategic Pipeline Advancements and Long-term Growth Potential
Praxis Precision Med Is Maintained at Outperform by Oppenheimer
Praxis Precision Medicine Analyst Ratings
Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $163
Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $143
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.